ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

ClinicalTrials.gov ID: NCT06834373

Public ClinicalTrials.gov record NCT06834373. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 2:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2 Study of Golcadomide With Rituximab as a Bridging Therapy Prior to CAR-T for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)

Study identification

NCT ID
NCT06834373
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mayo Clinic
Other
Enrollment
41 participants

Conditions and interventions

Conditions

Interventions

  • Biospecimen Collection Procedure
  • Bone Marrow Aspiration Procedure
  • Bone Marrow Biopsy Procedure
  • Chimeric Antigen Receptor T-Cell Therapy Biological
  • Computed Tomography Procedure
  • Golcadomide Drug
  • Leukapheresis Procedure
  • Positron Emission Tomography Procedure
  • Rituximab Biological

Procedure · Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1, 2025
Primary completion
Mar 2, 2027
Completion
Mar 2, 2027
Last update posted
Jan 27, 2026

2025 – 2027

United States locations

U.S. sites
7
U.S. states
4
U.S. cities
7
Facility City State ZIP Site status
Mayo Clinic in Arizona Scottsdale Arizona 85259 Recruiting
Mayo Clinic in Florida Jacksonville Florida 32224-9980 Recruiting
Mayo Clinic Health System in Albert Lea Albert Lea Minnesota 56007 Recruiting
Mayo Clinic Health Systems-Mankato Mankato Minnesota 56001 Recruiting
Mayo Clinic in Rochester Rochester Minnesota 55905 Recruiting
Mayo Clinic Health System-Eau Claire Clinic Eau Claire Wisconsin 54701 Recruiting
Mayo Clinic Health System-Franciscan Healthcare La Crosse Wisconsin 54601 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06834373, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 27, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06834373 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →